Angela Lax
Education
M.P.H., epidemiology, University of Minnesota School of Public Health; B.S., biology, Creighton University
Summary of Experience
Ms. Lax specializes in health care analytics, epidemiology, and health outcomes research. She has a strong background of using advanced quantitative methods to evaluate patient outcomes and generate real-world evidence. With extensive experience in designing and executing complex study designs and data analyses, her work spans a broad range of disease areas, including infectious diseases, mental health, oncology, autoimmune disorders, and rare diseases. Ms. Lax is accomplished in the conduct of observational and regulatory studies, including Food and Drug Administration (FDA) post-authorization safety studies, that utilize diverse health care data sources such as insurance claims, medical chart reviews, electronic medical records, and clinical trial data. Her expertise covers a wide array of therapeutic areas, and she has conducted studies assessing patient outcomes, treatment patterns, comparative effectiveness, drug safety, health care resource utilization, and treatment costs. Ms. Lax’s research has been presented to stakeholders at national and international conferences and published in peer-reviewed journals.
-
Healthcare Resource Use and Reimbursement Amount by Site of Care in Patients with Diffuse Large B-Cell Lymphoma Receiving Chimeric Antigen Receptor T-Cell (CAR-T) Therapy - a Retrospective Cohort Study Using CMS 100% Medicare Claims Database
Leukemia & Lymphoma, 2023
2023Yang H, Bollu V, Lim S, Tesfaye M, Dalal AA, Lax A, Sethi S, Zhao J
-
Impact of switching to infliximab biosimilars on treatment patterns among US veterans receiving innovator infliximab
Current Medical Research and Opinion, 2022
2022Lin I, Melsheimer R, Bhak RH, Lefebvre P, DerSarkissian M, Emond B, Lax A, Nguyen C, Wu M, Young-Xu Y
-
The acute effects of azithromycin use on cardiovascular mortality as compared with amoxicillin-clavulanate in US Veterans
Pharmacoepidemiology and Drug Safety, 2022
2022DerSarkissian M, Young-Xu Y, Duh MS, Bhak RH, Palmetto N, Mortensen E, Anzueto A, Nguyen C, Cheng M, Frajzyngier V, Park S, Lax A, Weatherby LB, Walker AM
-
Five-Year Estimated Glomerular Filtration Rate in Adults with Chronic Hypoparathyroidism Treated with rhPTH(1-84): A Retrospective Cohort Study
Advances in Therapy, 2022
2022Ayodele O, Rejnmark L, Mu F, Lax A, Berman R, Swallow E, Gosmanova EO
-
Real-World Treatment Patterns and Physician Preferences for Biologics in Moderate-to-Severe Inflammatory Bowel Disease: Retrospective Chart Review in Europe
Crohn's & Colitis 360, 2022
2022Huynh L, Hass S, Peyrin-Biroulet L, Duh MS, Sipsma H, Cheng M, Lax A, Nag A
-
August 26, 2024
-
October 23, 2023
-
August 30, 2022